Response-driven movement control with AUSTEDO1

Dial representing multiple dosing options that can range from 24mg/day to 48mg/day. Dial representing multiple dosing options that can range from 24mg/day to 48mg/day. In the FIRST-HD clinical trial, the mean total daily dose of AUSTEDO® (deutetrabenazine) tablets after titration was 40 mg.

AUSTEDO offers multiple therapeutic dosing options.1

Please see additional dosing and administration information at the bottom of this page.

AUSTEDO dosing should increase until symptom control is effectively and tolerably achieved1

Start treatment at 6 mg/day

Blue arrow pointing right Blue arrow pointing right

Increase by 6 mg/day weekly1

Ascending bar graph representing the titration schedule through Week 8 for patients with HD chorea. Ascending bar graph representing the titration schedule through Week 8 for patients with HD chorea.

AUSTEDO is available in 6-mg, 9-mg, and 12-mg tablets1

6 mg AUSTEDO®  (deutetrabenazine) tablet. 9 mg AUSTEDO®  (deutetrabenazine) tablet. 12 mg AUSTEDO®  (deutetrabenazine) tablet.

Tablets not shown at actual size.

Blue glass icon.

Additional dosing and
administration information1

  • Administer total daily dosages above 6 mg/day in 2 divided doses
  • AUSTEDO should be taken with food
  • AUSTEDO should be swallowed whole. Tablets should not be chewed, crushed, or broken
  • Starting dose differs for patients switching from tetrabenazine

REFERENCE: 1. AUSTEDO® (deutetrabenazine) tablets current Prescribing Information. Parsippany, NJ, Teva Neuroscience, Inc.